If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEdinburgh Worldwide Investment Trust Regulatory News (EWI)

Share Price Information for Edinburgh Worldwide Investment Trust (EWI)

Share Price is delayed by 15 minutes
Get Live Data
278.00    -11.00 (-3.81%)
Bid:
278.00
Ask:
279.00
Spread: 1.00 (0.36%)
Market Cap: £961.56m
EWI Live PriceLast checked at - London Stock Exchange

Intraday Edinburgh Worldwide Investment Trust Share Chart

EWIT RNS Holland 20 April AGM Statement Final

20 Apr 2026 07:46

RNS Number : 0959B
Edinburgh Worldwide Inv Trust PLC
20 April 2026
Β 

Β 

For immediate release

Β 

Legal Entity Identifier: 213800JUA8RKIDDLH380

Β 

20 April 2026

Β 

Edinburgh Worldwide Investment Trust plc

Β 

EWIT confirms intention to maintain existing investment mandate and provide those shareholders who do not support the investment strategy with an opportunity to exit via a tender offer following AGM

Β 

Independent Voting Advisors ISS, Glass Lewis and PIRC all recommend shareholders vote FOR the re-election of the independent Board members and AGAINST Saba's proposed nominees

Β 

The Board of Edinburgh Worldwide Investment Trust plc ("EWIT" or the "Company") today sets out its position and intentions should shareholders vote in favour of the independent Board at the AGM on 30 April 2026 and reject Saba Capital Management L.P.'s ("Saba") third attempt to take control of the Company.

Β 

It is evident that there are distinct shareholder groups with differing objectives. One group, comprising principally Saba, with the support of two other institutions, is seeking to take control of the Company by appointing its own board, replacing the manager and materially altering the investment strategy. At the other end of the spectrum, another group, representing the substantial majority of all other voting shareholders, has consistently supported the continuation of the Company's current mandate and the Path for Growth strategy, which has generated a total NAV return of 42.1% since its implementation and an 18.2% outperformance relative to its benchmark(1).

Β 

In the event that shareholders vote to retain the current Board and reject Saba's proposed nominees, the Board confirms that it will continue to pursue the Path for Growth strategy. This is Saba's third attempt to take control of the Company. A further rejection from shareholders would establish a clear mandate for the continuation of the Company and its unique mandate. The Board will continue to hold the manager to account for delivering long-term outperformance against the benchmark and for identifying opportunities that enable shareholders to benefit from the next generation of high-growth companies.

Β 

If the Board is retained at the AGM, it believes that repeated requisitions of this nature undermine orderly governance and will be strongly resisted. Furthermore, the Board welcomes the FCA's ongoing review of the regulatory framework and hopes it will strengthen criteria for board independence and conflicts of interest that are required to protect retail shareholders against a minority seeking to exploit it to take control.

Β 

Recognising the differing objectives of these shareholder groups, the Board reiterates its intention to seek to work with Saba and the other two institutions following the AGM to provide those shareholders who do not support the investment strategy with an opportunity to exit via a tender offer, while allowing those who support the Company and the independent Board to remain invested. The Board will continue to advocate strongly for the long-term investment case of EWIT.Β 

Β 

While the Board was disappointed by the outcome of the recent vote on the Tender Offer on 10 April 2026, the result was closely contested. Shareholders who support the continuation of EWIT in its current form should take confidence from this and recognise that a strong level of participation at the AGM, at least comparable to that seen in January 2026, will be critical in determining the outcome of the AGM.

Β 

The Board strongly recommends that shareholders VOTE IN FAVOUR of the Board resolutions at the AGM, including the election and re-election of the five current independent directors who remain committed to overseeing the Company on behalf of all shareholders. The Board strongly recommends that shareholders VOTE AGAINST the three resolutions proposed by Saba to appoint Gabriel Gliksberg, Jassen Trenkow and Michael Joseph as directors of the Company.

Β 

These recommendations are supported by independent voting advisers ISS, Glass Lewis and PIRC, all of whom have recommended that shareholders vote in line with the Board.

Β 

Jonathan Simpson-Dent, Chair of Edinburgh Worldwide, commented:

Β 

"We are extremely encouraged by strong and consistent support from the majority of shareholders we have engaged with, shareholders who are clear in their desire for EWIT to continue under its current mandate and who firmly oppose Saba's control agenda. We are standing up to protect their Company and uphold their clearly expressed wishes.

Β 

It is vital that all shareholders vote at this AGM. The outcome is not predetermined. If shareholders come out in significant numbers, there is a real opportunity to defeat Saba's proposals.

Β 

This is a decisive moment for the Company. A strong turnout and decisive vote will provide clarity, restore stability and allow EWIT to move forward with a clear mandate to execute its Path for Growth strategy. This strategy has already delivered strong outperformance since its implementation 18 months ago, and we firmly believe it represents the most compelling route to maximising long-term shareholder value.

Β 

We urge every shareholder to make their voice heard. Your vote matters. This is the moment to bring this uncertainty to a close and ensure the Company can focus, without distraction, on delivering for its investors."

Β 

For clarity, the Board will not present any further tender proposal before the outcome of the AGM.

Β 

(1) NAV total return for EWIT and S&P Global Small Cap Index for the period 31 October 2024 to 17 April 2026 (Source: Refinitiv Workspace).

Β 

For further information please contact:Β 

Β 

Investors:

Deutsche Numis

Nathan Brown

Tel: +44 20 7547 0569

Matt Goss

Tel: +44 20 7547 0541

Β 

Media:

Greenbrook Advisory

Peter Hewer / Rob White

+44 207 952 2000

ewit@greenbrookadvisory.comΒ 

Β 

Company Secretary:

Baillie Gifford & Co Limited

Tel 0131 275 2000

enquiries@bailliegifford.com

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGMFIFSRSIIIFIR
Date   Source Headline
12th May 202612:24 pmRNSNet Asset Value(s)
11th May 202611:08 amRNSNet Asset Value(s)
8th May 202611:50 amRNSNet Asset Value(s)
8th May 20267:00 amRNSEWIT Board and committee structure update
7th May 202612:02 pmRNSNet Asset Value(s)
6th May 202611:35 amRNSNet Asset Value(s)
6th May 202610:23 amRNSHolding(s) in Company
5th May 202611:31 amRNSNet Asset Value(s)
5th May 20268:32 amRNSNet Asset Value(s)
1st May 20263:28 pmRNSClosed Period Confirmation
1st May 20262:49 pmRNSNet Asset Value(s)
1st May 20269:36 amRNSStatement by the New Board
30th Apr 20261:19 pmRNSResult of AGM
30th Apr 202612:18 pmRNSNet Asset Value(s)
30th Apr 20267:00 amRNSEWIT AGM Update and Expected Voting Outcome
29th Apr 202611:20 amRNSNet Asset Value(s)
28th Apr 202611:41 amRNSNet Asset Value(s)
27th Apr 202612:25 pmRNSNet Asset Value(s)
24th Apr 20266:30 pmRNSEWIT confirms intention to give exit opportunities
24th Apr 202612:04 pmRNSNet Asset Value(s)
23rd Apr 202611:59 amRNSNet Asset Value(s)
22nd Apr 202611:33 amRNSNet Asset Value(s)
21st Apr 202611:33 amRNSNet Asset Value(s)
20th Apr 202612:16 pmRNSNet Asset Value(s)
20th Apr 20268:19 amRNSEWIT ISA GL and PIRC
20th Apr 20267:46 amRNSEWIT RNS Holland 20 April AGM Statement Final
17th Apr 202612:04 pmRNSNet Asset Value(s)
16th Apr 202611:26 amRNSNet Asset Value(s)
15th Apr 202611:38 amRNSNet Asset Value(s)
14th Apr 202612:15 pmRNSNet Asset Value(s)
13th Apr 20261:15 pmRNSResponse to Saba’s rejection of its own proposal
13th Apr 202611:34 amRNSNet Asset Value(s)
10th Apr 20264:52 pmRNSEWIT Result of Tender Offer Resolution
10th Apr 202611:35 amRNSNet Asset Value(s)
9th Apr 202611:40 amRNSNet Asset Value(s)
8th Apr 202611:34 amRNSNet Asset Value(s)
7th Apr 202612:22 pmRNSNet Asset Value(s)
7th Apr 202611:31 amRNSNet Asset Value(s)
7th Apr 202610:09 amRNSNet Asset Value(s)
7th Apr 20267:00 amRNSEdinburgh Worldwide Investment Trust Notice of AGM
1st Apr 20264:31 pmRNSNAV update and adjustment to valuation of SpaceX
1st Apr 20264:21 pmRNSNet Asset Value(s)
31st Mar 20263:03 pmRNSEWIT response to Saba Capital's last announcement
31st Mar 20261:14 pmRNSNet Asset Value(s)
30th Mar 202612:19 pmRNSNet Asset Value(s)
27th Mar 202611:55 amRNSNet Asset Value(s)
27th Mar 20268:53 amRNSAdvisers recommend voting for tender
26th Mar 202612:16 pmRNSNet Asset Value(s)
25th Mar 202612:21 pmRNSNet Asset Value(s)
24th Mar 20264:14 pmRNSFurther re: EWIT Q&A session on 27 March by Chair

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.